KKR & Co. Inc. (NYSE:KKR) Given New $194.00 Price Target at Bank of America

KKR & Co. Inc. (NYSE:KKR) had its price objective lowered by equities research analysts at Bank of America from $214.00 to $194.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a “buy” rating on the asset manager’s stock. Bank of America‘s price objective would suggest a potential upside of 109.18% from the stock’s current price.

A number of other brokerages also recently commented on KKR. HSBC downgraded shares of KKR & Co. Inc. from a “buy” rating to a “hold” rating and boosted their target price for the stock from $153.00 to $173.00 in a report on Thursday, January 30th. Hsbc Global Res cut shares of KKR & Co. Inc. from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 30th. Barclays lowered their target price on shares of KKR & Co. Inc. from $185.00 to $181.00 and set an “overweight” rating for the company in a research note on Wednesday, February 5th. Oppenheimer upped their price target on KKR & Co. Inc. from $153.00 to $175.00 and gave the stock an “outperform” rating in a research report on Thursday, December 12th. Finally, Keefe, Bruyette & Woods lowered their price objective on KKR & Co. Inc. from $170.00 to $168.00 and set an “outperform” rating for the company in a research report on Monday, January 13th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $163.00.

KKR & Co. Inc. Trading Down 9.6 %

Shares of NYSE:KKR opened at $92.74 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.82. The company has a market capitalization of $82.38 billion, a PE ratio of 27.85, a P/E/G ratio of 1.00 and a beta of 1.77. KKR & Co. Inc. has a 12-month low of $88.76 and a 12-month high of $170.40. The business’s fifty day simple moving average is $130.85 and its 200-day simple moving average is $141.06.

Insider Buying and Selling

In related news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the business’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the completion of the transaction, the insider now directly owns 19,260,971 shares in the company, valued at $634,841,604.16. The trade was a 23.75 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 39.34% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On KKR & Co. Inc.

A number of institutional investors have recently modified their holdings of KKR. McIlrath & Eck LLC purchased a new stake in shares of KKR & Co. Inc. in the fourth quarter worth about $26,000. Hanson & Doremus Investment Management acquired a new position in KKR & Co. Inc. in the fourth quarter valued at approximately $27,000. Crews Bank & Trust purchased a new stake in KKR & Co. Inc. in the 4th quarter worth approximately $30,000. Mascagni Wealth Management Inc. acquired a new stake in shares of KKR & Co. Inc. during the 4th quarter worth approximately $31,000. Finally, Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of KKR & Co. Inc. during the 4th quarter worth approximately $34,000. Hedge funds and other institutional investors own 76.26% of the company’s stock.

KKR & Co. Inc. Company Profile

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.